Petushkova A, Savvateeva L, Zamyatnin Jr A
Comput Struct Biotechnol J. 2022; 20:6552-6569.
PMID: 36467578
PMC: 9712828.
DOI: 10.1016/j.csbj.2022.11.040.
Fan W, Zhang W, Alshehri S, Garrison J
Eur J Med Chem. 2022; 234:114241.
PMID: 35306289
PMC: 9007894.
DOI: 10.1016/j.ejmech.2022.114241.
Fan W, Zhang W, Alshehri S, Neeley T, Garrison J
Eur J Med Chem. 2019; 177:386-400.
PMID: 31158752
PMC: 6636858.
DOI: 10.1016/j.ejmech.2019.05.068.
Siklos M, BenAissa M, Thatcher G
Acta Pharm Sin B. 2015; 5(6):506-19.
PMID: 26713267
PMC: 4675809.
DOI: 10.1016/j.apsb.2015.08.001.
Hook G, Jacobsen J, Grabstein K, Kindy M, Hook V
Front Neurol. 2015; 6:178.
PMID: 26388830
PMC: 4557097.
DOI: 10.3389/fneur.2015.00178.
Synaptic therapy in Alzheimer's disease: a CREB-centric approach.
Teich A, Nicholls R, Puzzo D, Fiorito J, Purgatorio R, Fa M
Neurotherapeutics. 2015; 12(1):29-41.
PMID: 25575647
PMC: 4322064.
DOI: 10.1007/s13311-014-0327-5.
Chemical biology approaches for the study of apicomplexan parasites.
Child M
Mol Biochem Parasitol. 2013; 192(1-2):1-9.
PMID: 24333788
PMC: 3945044.
DOI: 10.1016/j.molbiopara.2013.11.003.
Design, synthesis, and optimization of novel epoxide incorporating peptidomimetics as selective calpain inhibitors.
Schiefer I, Tapadar S, Litosh V, Siklos M, Scism R, Wijewickrama G
J Med Chem. 2013; 56(15):6054-68.
PMID: 23834438
PMC: 3962784.
DOI: 10.1021/jm4006719.
Cysteine cathepsins: from structure, function and regulation to new frontiers.
Turk V, Stoka V, Vasiljeva O, Renko M, Sun T, Turk B
Biochim Biophys Acta. 2011; 1824(1):68-88.
PMID: 22024571
PMC: 7105208.
DOI: 10.1016/j.bbapap.2011.10.002.
Calcium-dependent proteolytic activity of a cysteine protease caldonopain is detected during Leishmania infection.
Dey R, Bhattacharya J, Datta S
Mol Cell Biochem. 2005; 281(1-2):27-33.
PMID: 16328954
DOI: 10.1007/s11010-006-0171-y.
An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective.
Wang K, Nath R, Posner A, Raser K, Hajimohammadreza I, Probert A Jr W
Proc Natl Acad Sci U S A. 1996; 93(13):6687-92.
PMID: 8692879
PMC: 39087.
DOI: 10.1073/pnas.93.13.6687.
Biologically active monomeric and heterodimeric recombinant human calpain I produced using the baculovirus expression system.
Meyer S, Bozyczko-Coyne D, Mallya S, Spais C, Bihovsky R, Kaywooya J
Biochem J. 1996; 314 ( Pt 2):511-9.
PMID: 8670065
PMC: 1217080.
DOI: 10.1042/bj3140511.
Specificity of calcium-activated neutral proteinase (CANP) inhibitors for human mu CANP and mCANP.
Saito K, Nixon R
Neurochem Res. 1993; 18(2):231-3.
PMID: 8474564
DOI: 10.1007/BF01474689.
Catalytic-site characteristics of the porcine calpain II 80 kDa/18 kDa heterodimer revealed by selective reaction of its essential thiol group with two-hydronic-state time-dependent inhibitors: evidence for a catalytic site Cys/His interactive....
Mellor G, Sreedharan S, Kowlessur D, THOMAS E, Brocklehurst K
Biochem J. 1993; 290 ( Pt 1):75-83.
PMID: 8439300
PMC: 1132384.
DOI: 10.1042/bj2900075.
Studies of the active site of m-calpain and the interaction with calpastatin.
Crawford C, Brown N, Willis A
Biochem J. 1993; 296 ( Pt 1):135-42.
PMID: 8250833
PMC: 1137665.
DOI: 10.1042/bj2960135.
Human low-Mr kininogen contains three copies of a cystatin sequence that are divergent in structure and in inhibitory activity for cysteine proteinases.
Salvesen G, Parkes C, Abrahamson M, Grubb A, Barrett A
Biochem J. 1986; 234(2):429-34.
PMID: 3521586
PMC: 1146582.
DOI: 10.1042/bj2340429.
Elastinolytic activity of human cathepsin L.
Mason R, Johnson D, Barrett A, Chapman H
Biochem J. 1986; 233(3):925-7.
PMID: 3518704
PMC: 1153120.
DOI: 10.1042/bj2330925.
A cystatin-like cysteine proteinase inhibitor from venom of the African puff adder (Bitis arietans).
Evans H, Barrett A
Biochem J. 1987; 246(3):795-7.
PMID: 3500713
PMC: 1148349.
DOI: 10.1042/bj2460795.
The identification of the major excreted protein (MEP) from a transformed mouse fibroblast cell line as a catalytically active precursor form of cathepsin L.
Mason R, Gal S, Gottesman M
Biochem J. 1987; 248(2):449-54.
PMID: 3435459
PMC: 1148562.
DOI: 10.1042/bj2480449.
The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B.
Crawford C, Mason R, Wikstrom P, Shaw E
Biochem J. 1988; 253(3):751-8.
PMID: 2845932
PMC: 1149367.
DOI: 10.1042/bj2530751.